» Articles » PMID: 23071540

Gait Analysis in Rats with Single Joint Inflammation: Influence of Experimental Factors

Overview
Journal PLoS One
Date 2012 Oct 17
PMID 23071540
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Disability and movement-related pain are major symptoms of joint disease, motivating the development of methods to quantify motor behaviour in rodent joint pain models. We used observational scoring and automated methods to compare weight bearing during locomotion and during standing after single joint inflammation induced by Freund's complete adjuvant (0.12-8.0 mg/mL) or carrageenan (0.47-30 mg/mL). Automated gait analysis was based on video capture of prints generated by light projected into the long edge of the floor of a walkway, producing an illuminated image of the contact area of each paw with light intensity reflecting the contact pressure. Weight bearing was calculated as an area-integrated paw pressure, that is, the light intensity of all pixels activated during the contact phase of a paw placement. Automated static weight bearing was measured with the Incapacitance tester. Pharmacological sensitivity of weight-bearing during locomotion was tested in carrageenan-induced monoarthritis by administration of the commonly used analgesics diclofenac, ibuprofen, and naproxen, as well as oxycodone and paracetamol. Observational scoring and automated quantification yielded similar results. We found that the window between control rats and monoarthritic rats was greater during locomotion. The response was more pronounced for inflammation in the ankle as compared to the knee, suggesting a methodological advantage of using this injection site. The effects of both Freund's complete adjuvant and carrageenan were concentration related, but Freund's incomplete adjuvant was found to be as effective as lower, commonly used concentrations of the complete adjuvant. The results show that gait analysis can be an effective method to quantify behavioural effects of single joint inflammation in the rat, sensitive to analgesic treatment.

Citing Articles

Chronic inflammatory pain reduces fentanyl intake during early acquisition of fentanyl self-administration, but does not change motivation to take fentanyl in male and female rats.

Barattini A, Gilpin N, Pahng A Pharmacol Biochem Behav. 2024; 245():173890.

PMID: 39366430 PMC: 11624047. DOI: 10.1016/j.pbb.2024.173890.


The rat as a novel model for chronic rotator cuff injuries.

Yuan T, Lai C, Yang S, Meng J, Qian H, Yu X Sci Rep. 2024; 14(1):5344.

PMID: 38438458 PMC: 10912722. DOI: 10.1038/s41598-024-55281-5.


Opioids alter paw placement during walking, confounding assessment of analgesic efficacy in a postsurgical pain model in mice.

Brings V, Payne M, Gereau 4th R Pain Rep. 2022; 7(5):e1035.

PMID: 36034600 PMC: 9416758. DOI: 10.1097/PR9.0000000000001035.


Spontaneous, Voluntary, and Affective Behaviours in Rat Models of Pathological Pain.

Draxler P, Moen A, Galek K, Boghos A, Ramazanova D, Sandkuhler J Front Pain Res (Lausanne). 2022; 2:672711.

PMID: 35295455 PMC: 8915731. DOI: 10.3389/fpain.2021.672711.


Targeted mesenchymal stem cell therapy equipped with a cell-tissue nanomatchmaker attenuates osteoarthritis progression.

Nasiri N, Hosseini S, Reihani-Sabet F, Baghaban Eslaminejad M Sci Rep. 2022; 12(1):4015.

PMID: 35256711 PMC: 8901617. DOI: 10.1038/s41598-022-07969-9.


References
1.
Sun S, Cao H, Han M, Li T, Zhao Z, Zhang Y . Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis. Brain Res Bull. 2007; 75(1):83-93. DOI: 10.1016/j.brainresbull.2007.07.027. View

2.
Hong S, Han J, Min S, Hwang J, Kim Y, Na H . Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat. Neurosci Lett. 2002; 322(1):21-4. DOI: 10.1016/s0304-3940(02)00070-8. View

3.
Coulthard P, Simjee S, Pleuvry B . Gait analysis as a correlate of pain induced by carrageenan intraplantar injection. J Neurosci Methods. 2003; 128(1-2):95-102. DOI: 10.1016/s0165-0270(03)00154-7. View

4.
Conrozier T, Bertin P, Bailleul F, Mathieu P, Charlot J, Vignon E . Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine. 2006; 73(6):705-9. DOI: 10.1016/j.jbspin.2006.02.008. View

5.
Ferland C, Laverty S, Beaudry F, Vachon P . Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav. 2010; 97(3):603-10. DOI: 10.1016/j.pbb.2010.11.003. View